Year archive

Schott Pharma — 2024 filings

All 65 regulatory filings released by Schott Pharma (1SXP) in 2024, sourced directly from the official regulator.

65 Filings

2024 Period

2024 filings (65)

Filing	Released	Lang
SCHOTT Pharma 2024 Präsentation (englisch) Investor Presentation	2024-12-17	English
Sustainability Report 2023/2024 Environmental & Social Information	2024-12-17	English
SCHOTT Pharma with strong growth and record margin after solid year-end finish Earnings Release FY 2024	2024-12-13	English
SCHOTT Pharma with strong growth and record margin after solid year-end finish Earnings Release FY 2024	2024-12-12	English
Sustainability Report 2023/2024 Environmental & Social Information	2024-12-12	English
Annual financial report 2023/2024 Annual Report FY 2024	2024-12-12	English
Remuneration Report 2023/2024 Remuneration Information	2024-12-12	English
SCHOTT Pharma 2024 Presentation Investor Presentation	2024-12-12	English
Financial Statement of SCHOTT Pharma AG & Co. KGaA (HGB) 2023/2024 Annual Report FY 2024	2024-12-12	English
SCHOTT Pharma 2024 Präsentation (englisch) Investor Presentation	2024-12-12	English
Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges Regulatory Filings	2024-12-04	English
2024 September Declarations of Conformity (German) Governance Information	2024-12-03	German
2024 December Declarations of Corporate Governance (german) Governance Information	2024-12-03	German
Report Publication Announcement 2024 Report Publication Announcement	2024-11-11	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-09-27	English
SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry Alliance for RTU Regulatory Filings	2024-09-26	English
Articles of association of the company (German) Governance Information	2024-09-17	German
Articles of association of the company (German) Regulatory Filings	2024-09-17	German
Satzung der Gesellschaft Regulatory Filings	2024-09-17	German
Promotion for SCHOTT Pharma: Listed on the MDAX for the first time Delisting Announcement	2024-09-05	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-09-03	English
SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance Earnings Release Q3 2024	2024-08-29	English
Presentation 9M 2023/2024 Investor Presentation	2024-08-29	English
Präsentation 9M 2023/2024 (englisch) Investor Presentation	2024-08-29	English
Q3 statement / Q3 financial report 2023/2024 Interim / Quarterly Report 9M 2024	2024-08-29	English
SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement Environmental & Social Information	2024-08-08	English
Jahresabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023 Audit Report / Information FY 2023	2024-08-07	German
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-08-05	English
Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes Regulatory Filings	2024-07-31	English
Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices Regulatory Filings	2024-07-16	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-07-04	English
SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 Earnings Release Q2 2024	2024-06-27	English
Half-yearly financial report 2023/2024 Interim / Quarterly Report H1 2024	2024-06-27	English
Presentation H1 2023/2024 Earnings Release H1 2024	2024-06-27	English
Präsentation H1 2023/2024 (englisch) Investor Presentation	2024-06-27	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-24	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-24	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-17	English
Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukacshaza, Hungary Regulatory Filings	2024-06-14	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-23	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-17	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-17	English
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes Earnings Release H1 2024	2024-05-14	English
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes Earnings Release FY 2025	2024-05-14	English
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations Board/Management Information	2024-04-30	English
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility Regulatory Filings	2024-03-18	English
Vergütungsbericht 2022/2023 Remuneration Information	2024-03-15	German
Remuneration Report 2022/2023 Remuneration Information	2024-03-15	English
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda AGM Information	2024-03-14	English
Remuneration System for the Members of the Supervisory Board Remuneration Information	2024-03-14	English
Remuneration System for the Members of the Management Board of the personally liable partner Remuneration Information	2024-03-14	English
SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell Director's Dealing	2024-03-04	English
SCHOTT Pharma reports good start into fiscal year 2024 Earnings Release Q1 2024	2024-02-29	English
Q1 statement / Q1 financial report 2023/2024 Interim / Quarterly Report Q1 2024	2024-02-29	English
Presentation Q1 2023/2024 Investor Presentation	2024-02-29	English
Präsentation Q1 2023/2024 (englisch) Investor Presentation	2024-02-29	English
Report Publication Announcement 2024 Report Publication Announcement	2024-02-26	English
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory Earnings Release FY 2023	2024-01-26	English
Financial Statement of SCHOTT Pharma AG & Co. KGaA (HGB) 2022/2023 Annual Report FY 2023	2024-01-26	English
Annual financial report 2022/2023 (PDF) Annual Report FY 2023	2024-01-26	English
Sustainability Report 2022/2023 Environmental & Social Information	2024-01-26	English
Jahresabschluss der SCHOTT AG & Co. KGaA (HGB) 2022/2023 Annual Report FY 2023	2024-01-26	German
SCHOTT Pharma 2023 Presentation Investor Presentation	2024-01-26	English
SCHOTT Pharma 2023 Präsentation (englisch) Investor Presentation	2024-01-26	English
Report Publication Announcement 2024 Report Publication Announcement	2024-01-15	English